Page last updated: 2024-08-25

ljc 10627 and meropenem

ljc 10627 has been researched along with meropenem in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's18 (38.30)18.2507
2000's15 (31.91)29.6817
2010's9 (19.15)24.3611
2020's5 (10.64)2.80

Authors

AuthorsStudies
Jolivette, LJ; Ward, KW1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Distèche-Nguyen, M; Gerards, T; Luxen, A; Miguet, L; Pasha, FA; Thomas, A; Zervosen, A1
Eto, M; Ishii, Y; Mano, Y; Tateda, K; Yamaguchi, K1
Abendroth, J; Atkins, K; Boyer, SH; Clifton, MC; Dudley, MN; Durso, S; Griffith, DC; Hecker, SJ; Hirst, GC; King, P; Lomovskaya, O; Loutit, JS; Morgan, EE; Potts, KT; Raymond, A; Reddy, KR; Sabet, M; Sun, D; Tarazi, Z; Totrov, M; Tsivkovski, R1
Bell, DT; Culhane, JC; Ebner, DC; Heuer, AM; Ippoliti, JT; Kaushik, A; Lamichhane, G; Parrish, N1
Castagnolo, D; Denny, WA; Dos Santos, JL; Fernandes, GFS; Thompson, AM1
Ichihara, Y; Mikami, Y; Miyaji, M; Nishimura, C; Ohashi, S; Yazawa, K1
Bland, S; Dubreuil, L; Grollier, G; Houcke, I; Mory, F; Sedallian, A1
Hikida, M; Kawashima, K; Mitsuhashi, S; Nishiki, K; Yamazaki, Y; Yoshida, M1
Day, IP; Goudie, J; Nishiki, K; Williams, PD1
Andrews, JM; Boswell, FJ; Gill, MJ; Wise, R1
Bhachech, N; Bush, K; Yang, Y1
Aldridge, KE; Morice, N; Schiro, DD1
Chen, HY; Livermore, DM1
Jones, RN; Sader, HS1
Hashizume, T; Hazumi, N; Kato, Y; Matsuda, K1
Kumazawa, J; Matsumoto, T; Nagayama, A1
Kanazawa, K; Nouda, H; Sunagawa, M1
Hirata, Y; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kawaguchi, R; Kobayashi, I; Kumasaka, K; Matsuoka, K; Murakami, E; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Okamoto, E; Saeki, H; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uchida, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H1
Awaya, Y; Fujiue, Y; Kodomari, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y1
Horii, T; Ichiyama, S; Kobayashi, M; Ohta, M1
Hirata, Y; Hongo, T; Igari, J; Imafuku, Y; Inoue, M; Kawaguchi, R; Kobayashi, I; Kobayasi, Y; Kumasaka, K; Matsumoto, N; Nakasaki, N; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Saeki, H; Sasaki, T; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H1
Murase, M1
Fujimura, S; Gomi, K; Honda, Y; Kikuchi, T; Kobayashi, T; Nukiwa, T; Shoji, S; Takahashi, H; Tokue, Y; Watanabe, A; Yasui, S1
Aoki, N; Hashimoto, T; Hirata, Y; Hongo, T; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kajimura, K; Kawaguchi, R; Kobayashi, I; Kobayashi, Y; Kumasaka, K; Matsumoto, N; Matsuoka, K; Murakami, E; Nakasaki, N; Nishino, T; Oguri, T; Ohba, Y; Ohtaki, Y; Okada, J; Okamoto, E; Ono, J; Saeki, H; Sasaki, T; Satou, S; Shibano, T; Takahashi, A; Takata, T; Tokuda, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H1
Endo, H; Jinbo, K; Nishinari, C; Suzuki, Y; Tamura, C1
Hikida, M; Inoue, M; Okamoato, R; Sato, Y; Terashima, S1
Araake, M; Gotoh, N; Hiraishi, T; Miyata, A; Nishino, T; Ogawa, H; Takata, T1
Araake, M; Hara, T; Watabe, H1
Inoue, M; Kaku, M; Nasu, M; Sagawa, K; Yokoyama, T1
Aizawa, K; Sakakibara, S; Shimizu, A; Takata, T; Totsuka, K; Watabe, H1
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T1
Doi, M; Fujiue, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y; Yano, S1
Kobayashi, Y; Sumitani, Y1
Mikamo, H; Tanaka, K; Watanabe, K; Yamagishi, Y1
Derendorf, H; Ikawa, K; Ikeda, K; Morikawa, N; Murakami, Y; Nakashima, A; Ohge, H; Sueda, T1
Araki, N; Harada, Y; Hasegawa, H; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Yamada, K; Yamamoto, Y; Yanagihara, K1
Ding, G; Hao, Q; Hu, C; Liu, H; Lv, X; Qin, Z; Tong, C; Wang, X; Xin, J; Xiong, Y; Yu, R; Zhang, X; Zong, Z1
Kaushik, A; Lamichhane, G; Makkar, N; Pandey, P; Parrish, N; Singh, U1
Ji, S; Li, C; Li, S; Liang, X; Zhang, F; Zhu, Y1
Bell, DT; Chauhan, V; Kaushik, A; Kumar, P; Lamichhane, G; Stevens, RL; Xia, F1
Li, X; Lu, C; Sun, S; Wang, D; Wang, Y1
Akao, T; Ichimura, Y; Kudoh, N; Murabe, T; Oda, M; Saito, T; Saitoh, H; Suzuki, T; Watanuki, S1
Tiwaskar, M; Vora, A1
George Priya Doss, C; Gopikrishnan, M1

Reviews

1 review(s) available for ljc 10627 and meropenem

ArticleYear
Tuberculosis Drug Discovery: Challenges and New Horizons.
    Journal of medicinal chemistry, 2022, 06-09, Volume: 65, Issue:11

    Topics: Antitubercular Agents; COVID-19 Drug Treatment; Drug Discovery; Humans; Mycobacterium tuberculosis; Tuberculosis

2022

Trials

1 trial(s) available for ljc 10627 and meropenem

ArticleYear
Biapenem versus meropenem in the treatment of bacterial infections: a multicenter, randomized, controlled clinical trial.
    The Indian journal of medical research, 2013, Volume: 138, Issue:6

    Topics: Adult; Aged; Bacteria; Bacterial Infections; China; Female; Humans; Infusions, Intravenous; Male; Meropenem; Middle Aged; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections

2013

Other Studies

45 other study(ies) available for ljc 10627 and meropenem

ArticleYear
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7

    Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution

2005
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
    Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19

    Topics: Computational Biology; Computer Simulation; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ligands; Penicillin-Binding Proteins; Protein Binding; Streptococcus pneumoniae; Structure-Activity Relationship

2009
In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa

2010
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases.
    Journal of medicinal chemistry, 2015, May-14, Volume: 58, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Carbapenems; Crystallography, X-Ray; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Heterocyclic Compounds, 1-Ring; Mice; Microbial Sensitivity Tests; Models, Molecular; Rats; Stereoisomerism; Structure-Activity Relationship

2015
An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.
    Bioorganic & medicinal chemistry letters, 2016, 08-01, Volume: 26, Issue:15

    Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Structure-Activity Relationship

2016
In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:2

    Topics: Carbapenems; Imipenem; Meropenem; Microbial Sensitivity Tests; Nocardia; Thienamycins

1992
[In vitro activity of carbapenems (biapenem, imipenem and meropenem) and some other antibiotics against strict anaerobic bacteria].
    Pathologie-biologie, 1995, Volume: 43, Issue:4

    Topics: Bacteroides fragilis; Clostridium; Dose-Response Relationship, Drug; Eubacterium; Fusobacterium; Humans; Imipenem; In Vitro Techniques; Meropenem; Peptostreptococcus; Prevotella; Thienamycins

1995
Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
    The Journal of antibiotics, 1995, Volume: 48, Issue:8

    Topics: Animals; Ceftazidime; Cephalosporins; Female; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1995
Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem.
    Toxicology letters, 1995, Volume: 76, Issue:3

    Topics: Analysis of Variance; Animals; Binding, Competitive; Cilastatin; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Imipenem; Injections, Intravenous; Male; Meropenem; Mice; Muscimol; Pentylenetetrazole; Rats; Receptors, GABA-A; Seizures; Thienamycins

1995
Postantibiotic effects of three carbapenems on Pseudomonas aeruginosa in the presence of lysine.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:1

    Topics: Carbapenems; Imipenem; Lysine; Meropenem; Pseudomonas aeruginosa; Thienamycins

1995
Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:1

    Topics: Bacteria; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cell Membrane Permeability; Hexosyltransferases; Hydrolysis; Imipenem; Kinetics; Meropenem; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Thienamycins

1995
In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:4

    Topics: Bacteria, Anaerobic; beta-Lactamases; Drug Resistance, Microbial; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

1994
In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    The Journal of antimicrobial chemotherapy, 1994, Volume: 33, Issue:5

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Enzyme Induction; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Penicillin Resistance; Porins; Pseudomonas aeruginosa; Thienamycins

1994
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:5

    Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Ceftazidime; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

1993
Effects of a beta-lactamase inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa.
    The Journal of antibiotics, 1995, Volume: 48, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Drug Synergism; Enzyme Inhibitors; Imipenem; Meropenem; Pseudomonas aeruginosa; Sulbactam; Thienamycins

1995
Sensitivities to four carbapenems of bacteria isolated from patients with refractory complicated urinary tract infections and the detection of carbapenemase-producing Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins; Urinary Tract Infections

1996
Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain.
    The Journal of antibiotics, 1997, Volume: 50, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Haemophilus influenzae; Hexosyltransferases; Imipenem; Meropenem; Methylation; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Structure-Activity Relationship; Thienamycins

1997
[Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:8

    Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins

1997
[The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serotyping; Sputum; Thienamycins

1998
Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa.
    Journal of medical microbiology, 1999, Volume: 48, Issue:3

    Topics: Carbapenems; Endotoxins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1999
[Survey of the sensitivities of clinical isolates to antibacterial agents (annual report)].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:4

    Topics: Carbapenems; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Time Factors

1999
[In vitro antibacterial activities of carbapenems against clinical isolates].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:11

    Topics: Bacteria; Enterobacteriaceae; Imipenem; Meropenem; Methicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins

1999
[In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
    The Japanese journal of antibiotics, 1999, Volume: 52, Issue:12

    Topics: Bacteria; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Penicillins; Piperacillin; Respiratory Tract Infections; Thienamycins; Time Factors

1999
[Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:3

    Topics: Bacteria; Carbapenems; Drug Resistance, Microbial; Humans; Imipenem; Japan; Meropenem; Multicenter Studies as Topic; Thienamycins; Time Factors

2000
[Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:9

    Topics: Bacteria; Carbapenems; Cefepime; Cefozopran; Cephalosporins; Imipenem; Meropenem; Thienamycins

2001
[Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
    The Japanese journal of antibiotics, 2001, Volume: 54, Issue:11

    Topics: beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Imipenem; Meropenem; Pseudomonas aeruginosa; Thienamycins

2001
[Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:1

    Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Imipenem; Meropenem; Mutation; Pseudomonas aeruginosa; Thienamycins

2002
[Antibacterial activity of biapenem against recent clinical isolates].
    The Japanese journal of antibiotics, 2003, Volume: 56, Issue:2

    Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins

2003
[Proper use of carbapenem antibiotics based on the feature in the treatment of infectious diseases (discussion)]].
    The Japanese journal of antibiotics, 2004, Volume: 57, Issue:1

    Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins; Treatment Failure

2004
Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2004, Volume: 10, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Drug Administration Schedule; Humans; Imipenem; Male; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Thigh

2004
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins

2006
[Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:2

    Topics: Amikacin; Anti-Infective Agents; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Meropenem; Oxazines; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Urine

2006
[Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory].
    The Japanese journal of antibiotics, 2007, Volume: 60, Issue:6

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Meropenem; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2007
[Clinical investigation on target value of T>MIC in carbapenems].
    The Japanese journal of antibiotics, 2008, Volume: 61, Issue:2

    Topics: Adult; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Drug Administration Schedule; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Meropenem; Middle Aged; Pelvic Inflammatory Disease; Staphylococcus aureus; Thienamycins

2008
Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target attainment.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bile; Biliary Tract; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2011
In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Colony Count, Microbial; Disease Models, Animal; Histocytochemistry; Lung; Male; Meropenem; Mice; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms; Statistics, Nonparametric; Thienamycins

2012
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Doripenem; Drug Synergism; Meropenem; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Thienamycins

2015
[Analysis of carbapenems by hydrophilic interaction chromatography and its application].
    Se pu = Chinese journal of chromatography, 2015, Volume: 33, Issue:9

    Topics: beta-Lactams; Carbapenems; Chromatography; Doripenem; Drinking Water; Ertapenem; Humans; Hydrophobic and Hydrophilic Interactions; Meropenem; Thienamycins

2015
Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3

    Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; Cephalosporins; Clavulanic Acid; DNA, Intergenic; Gene Expression; Genetic Loci; Humans; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Open Reading Frames; Protein Binding; Thienamycins; Tuberculosis, Multidrug-Resistant

2017
In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii.
    Letters in applied microbiology, 2020, Volume: 70, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Ambroxol; Amlodipine; Anti-Bacterial Agents; Carbapenems; Cefoperazone; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins

2020
Inhibitory effects of indoxyl sulfate and creatinine on the renal transport of meropenem and biapenem in rats.
    Drug metabolism and pharmacokinetics, 2021, Volume: 40

    Topics: Animals; Creatinine; Humans; Indican; Kidney; Meropenem; Organic Anion Transporters, Sodium-Independent; Rats; Thienamycins; Uremic Toxins

2021
Biapenem.
    The Journal of the Association of Physicians of India, 2022, Volume: 70, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins

2022
Molecular docking and dynamic approach to screen the drug candidate against the Imipenem-resistant CarO porin in Acinetobacter baumannii.
    Microbial pathogenesis, 2023, Volume: 177

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Carbapenems; Doripenem; Ertapenem; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Porins

2023